Evidence map›Paper›PMID 35112318›Full record

ReviewMolecular neurobiology2022

An update on the roles of circular RNAs in spinal cord injury.

Xuezhen Ma, Xuesong Wang, Xuexiao Ma, Xiugong Zhang, Xiaojin Gong, Ruifu Sun, Sunny H Wong, Matthew T V Chan, William Ka Kei Wu

Abstract readReview
PubMed Publisher
In one paragraph

Review in Molecular neurobiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. MicroRNAs in spinal cord injury: A narrative review.Frontiers in molecular neuroscience · 2023
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Xuezhen MaDepartment Oncology of Qingdao Hospital Central, Central Qingdao Hospital, Qingdao, Shandong, China.
Xuesong WangDepartment Spinal of Qingdao Hospital Central, Qingdao Hospital Central, Qingdao, Shandong, China. xuesongwangq@163.com.ORCID http://orcid.org/0000-0001-8667-3959
Xuexiao MaDepartment Spinal of affiliated, Hospital of Qingdao University, Qingdao, Shandong, China.
Xiugong ZhangDepartment Spinal of Qingdao Hospital Central, Qingdao Hospital Central, Qingdao, Shandong, China.
Xiaojin GongDepartment Spinal of Qingdao Hospital Central, Qingdao Hospital Central, Qingdao, Shandong, China.
Ruifu SunDepartment Spinal of Qingdao Hospital Central, Qingdao Hospital Central, Qingdao, Shandong, China.
Sunny H WongLee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Matthew T V ChanDepartment of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, China.
William Ka Kei WuState Key Laboratory of Digestive Disease and LKS Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Qingdao University · CNChinese University of Hong Kong · HKNanyang Technological University · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spinal cord injury (SCI) is a disabling condition for which therapeutic options are limited. Increasing number of microarray and next-generation sequencing studies have demonstrated that SCI coincides with altered expression of circular RNAs (circRNAs) in the damaged tissue. Emerging functional evidence further pinpointed specific differentially expressed circRNAs (e.g., circ-HIPK3, cicRNA.7079, circRNA_01477, circRNA-2960, and circ_0001723) for their effects on cellular processes relevant to SCI repair and regeneration, including neuronal apoptosis, astrocyte activation, and neuroinflammation, via sponging SCI-related microRNAs. Although circRNAs and their target microRNAs appear to be good candidates for therapeutic exploitation in SCI, further investigation into the efficient delivery of these regulatory molecules in a cell-type specific manner is a pre-requisite for translating these basic discoveries into clinical benefits.

Indexed as

MicroRNAsSpinal Cord InjuriesApoptosisGene Regulatory NetworksHumansRNA, CircularMicroRNAsRNA, CircularceRNAcircRNAmicroRNASpinal cord injury

Identifiers

PMID35112318
OpenAlexW4210609271

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.